UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 169

Sortiert nach

Functional and genetic deconstruction of the cellular origin in liver cancer

Nature reviews. Cancer, 2015-11, Vol.15 (11), p.653

2015

Volltextzugriff (PDF)

Predisposition to Apoptosis in Hepatocellular Carcinoma: From Mechanistic Insights to Therapeutic Strategies

Frontiers in oncology, 2019-12, Vol.9, p.1421-1421

2019

Volltextzugriff (PDF)

Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies

Journal of hepatology, 2012-01, Vol.56 (1), p.267-275

2012

Volltextzugriff (PDF)

Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer

Nature communications, 2022-12, Vol.13 (1), p.7533-7533, Article 7533

2022

Volltextzugriff (PDF)

RNA-Seq Atlas—a reference database for gene expression profiling in normal tissue by next-generation sequencing

Bioinformatics (Oxford, England), 2012-04, Vol.28 (8), p.1184-1185

2012

Volltextzugriff (PDF)

Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer-from Tumor Development to Therapeutic Implications

Cancers, 2019-07, Vol.11 (8), p.1053

2019

Volltextzugriff (PDF)

Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer

Gastroenterology (New York, N.Y. 1943), 2017-06, Vol.152 (8), p.2037-2051.e22

2017

Volltextzugriff (PDF)

Tailored Systemic Therapy for Colorectal Cancer Liver Metastases

International journal of molecular sciences, 2021-10, Vol.22 (21), p.11780

2021

Volltextzugriff (PDF)

Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types

Gastroenterology (New York, N.Y. 1943), 2013-07, Vol.145 (1), p.221-231

2013

Volltextzugriff (PDF)

CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma

International journal of molecular sciences, 2022-08, Vol.23 (15), p.8616

2022

Volltextzugriff (PDF)

Evaluation of the Diagnostic Value of Oesophageal Biopsies for Direct Immunofluorescence Microscopy in Mucous Membrane Pemphigoid

Acta dermato-venereologica, 2023-08, Vol.103, p.adv11947-adv11947

2023

Volltextzugriff (PDF)

Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers

Cancers, 2022-03, Vol.14 (7), p.1722

2022

Volltextzugriff (PDF)

MYC Activates Stem-like Cell Potential in Hepatocarcinoma by a p53-Dependent Mechanism

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20), p.5903-5913

2014

Volltextzugriff (PDF)

Distinguishing the impact of distinct obstructive sleep apnea syndrome (OSAS) and obesity related factors on human monocyte subsets

Scientific reports, 2024-01, Vol.14 (1), p.340-340, Article 340

2024

Volltextzugriff (PDF)

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis

Health and quality of life outcomes, 2022-02, Vol.20 (1), p.23-23, Article 23

2022

Volltextzugriff (PDF)

DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration

Hepatology (Baltimore, Md.), 2016-08, Vol.64 (2), p.582-598

2016

Volltextzugriff (PDF)

Translational Considerations to Improve Response and Overcome Therapy Resistance in Immunotherapy for Hepatocellular Carcinoma

Cancers, 2020-09, Vol.12 (9), p.2495

2020

Volltextzugriff (PDF)

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

Therapeutic advances in medical oncology, 2022-02, Vol.14, p.17588359221080298-17588359221080298

2022

Volltextzugriff (PDF)

Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits

Journal of hepatology, 2014-02, Vol.60 (2), p.346-353

2014

Volltextzugriff (PDF)

Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling

Genes & development, 2013-08, Vol.27 (15), p.1706-1717

2013

Volltextzugriff (PDF)

Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program

BMC cancer, 2019-01, Vol.19 (1), p.55-10, Article 55

2019

Volltextzugriff (PDF)

Antitumor Effects in Hepatocarcinoma of Isoform-Selective Inhibition of HDAC2

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (17), p.4752-4761

2014

Volltextzugriff (PDF)

Mitochondrial BAX Determines the Predisposition to Apoptosis in Human AML

Clinical cancer research, 2017-08, Vol.23 (16), p.4805-4816

2017

Volltextzugriff (PDF)

An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer

Science translational medicine, 2010-10, Vol.2 (54), p.54ra77

2010

Volltextzugriff (PDF)

Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing

Cell reports (Cambridge), 2023-11, Vol.42 (11), p.113446-113446, Article 113446

2023

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(156)

Publikationsform

Sprache

Englisch
(164)
Japanisch
(27)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(127)
Life Sciences & Biomedicine
(120)
Humans
(73)
Gastroenterology & Hepatology
(49)
Liver Cancer
(40)
Oncology
(37)
Animals
(35)
Hepatocellular Carcinoma
(33)
Liver Neoplasms - Pathology
(27)
Tumors
(27)
Male
(26)
Liver Neoplasms - Genetics
(25)
Carcinoma, Hepatocellular - Genetics
(23)
Mice
(23)
Female
(21)
Carcinoma, Hepatocellular - Pathology
(19)
Liver
(19)
Cell Biology
(17)
Prognosis
(17)
Cancer
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Functional and genetic deconstruction of the cellular origin in liver cancer

Predisposition to Apoptosis in Hepatocellular Carcinoma: From Mechanistic Insights to Therapeutic Strategies

Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies

Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer

RNA-Seq Atlas—a reference database for gene expression profiling in normal tissue by next-generation sequencing

Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer-from Tumor Development to Therapeutic Implications

Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer

Tailored Systemic Therapy for Colorectal Cancer Liver Metastases

Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types

CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma

Evaluation of the Diagnostic Value of Oesophageal Biopsies for Direct Immunofluorescence Microscopy in Mucous Membrane Pemphigoid

Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers

MYC Activates Stem-like Cell Potential in Hepatocarcinoma by a p53-Dependent Mechanism

Distinguishing the impact of distinct obstructive sleep apnea syndrome (OSAS) and obesity related factors on human monocyte subsets

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis

DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration

Translational Considerations to Improve Response and Overcome Therapy Resistance in Immunotherapy for Hepatocellular Carcinoma

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits

Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling

Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program

Antitumor Effects in Hepatocarcinoma of Isoform-Selective Inhibition of HDAC2

Mitochondrial BAX Determines the Predisposition to Apoptosis in Human AML

An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer

Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing

Suchergebnisse filtern